No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs530948716 |
chr14:67656204-67656205 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs549550488 |
chr14:67656210-67656211 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs567820873 |
chr14:67656283-67656284 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs535247089 |
chr14:67656310-67656311 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs549727080 |
chr14:67656342-67656343 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs547287672 |
chr14:67656347-67656348 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs557498628 |
chr14:67656361-67656362 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs571999899 |
chr14:67656368-67656369 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs567946790 |
chr14:67656393-67656394 |
Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs372960086 |
chr14:67656408-67656409 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs539406315 |
chr14:67656432-67656433 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs557511063 |
chr14:67656454-67656455 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs373247796 |
chr14:67656546-67656547 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs528914458 |
chr14:67656594-67656595 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs186078043 |
chr14:67656639-67656640 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs536703311 |
chr14:67656661-67656662 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs555051007 |
chr14:67656682-67656683 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs573464192 |
chr14:67656683-67656684 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs376544347 |
chr14:67656691-67656692 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs7150934 |
chr14:67656715-67656716 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
21 |
rs565785536 |
chr14:67656731-67656732 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs111315013 |
chr14:67656732-67656733 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs559197684 |
chr14:67656761-67656762 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs143684729 |
chr14:67656767-67656768 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs35176263 |
chr14:67656785-67656786 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs28552859 |
chr14:67656786-67656787 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs71129813 |
chr14:67656805-67656806 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs8014435 |
chr14:67656807-67656808 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs199680550 |
chr14:67656808-67656809 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs373691563 |
chr14:67656832-67656833 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs545375002 |
chr14:67656901-67656902 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs543133394 |
chr14:67656911-67656912 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs112895464 |
chr14:67656917-67656918 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs368581468 |
chr14:67656944-67656945 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs142361812 |
chr14:67656945-67656946 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs57073031 |
chr14:67656951-67656952 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs397978046 |
chr14:67656958-67656959 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs371703406 |
chr14:67657004-67657005 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs530945113 |
chr14:67657043-67657044 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs549175497 |
chr14:67657044-67657045 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs561391143 |
chr14:67657050-67657051 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs528677270 |
chr14:67657051-67657052 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs373353330 |
chr14:67657096-67657097 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs547251008 |
chr14:67657117-67657118 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs190402475 |
chr14:67657121-67657122 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs113066287 |
chr14:67657142-67657143 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs375309721 |
chr14:67657143-67657144 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs571963225 |
chr14:67657160-67657161 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs147672991 |
chr14:67657220-67657221 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs111659767 |
chr14:67657227-67657228 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|